TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.

By B. D. Lawrence, A. Perez-Atayde, M. Hibbard, B. Rubin, P. Cin, J. Pinkus, G. Pinkus, S. Xiao, E. Yi, C. Fletcher and 1 more. American Journal of Pathology, 2000

689 citations recorded by the source corpus.

Subfields: Epidemiology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/ad34bb142e4c2e41676c349b7dec0cbad2a5aba3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. B. Rubin
2. S. Singer
3. J. Fletcher
4. D. Tuveson
5. Connie W. Tsao
6. A. Duensing
7. Chang-jie Chen
8. Robert Ruiz

Citations in the corpus

• KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. (2001, background): “(Zymed Laboratories, South San Francisco, CA) as described previously (26).”